The present invention provides a substituted macrocyclic oozine compound and its pharmaceutical composition and its pharmaceutical compositions and applications, such as compounds such as I, or their polycrystalline, pharmaceutically acceptable salts, prodrugs, stereoisomers, isotopic variants, hydrates, or solvent compounds. The compound can be used as an inhibitor of hepatitis C virus, and has a better inhibitory activity of hepatitis C virus protein NS3A, has better pharmacodynamics / pharmacokinetics, good applicability and high safety, and can be used in the preparation of hepatitis C virus infection drug, and has a good market development prospect.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请,说明书已公开。
【技术保护点】
PCT国内申请,权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.05....
【专利技术属性】
技术研发人员:王义汉,赵九洋,
申请(专利权)人:深圳市塔吉瑞生物医药有限公司,
类型:发明
国别省市:广东,44
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。